Gene Page:Bard1
Summary?
基因 | 580 |
象征 | Bard1 |
Synonyms | - |
Description | BRCA1相关环域1 |
Reference | MIM:601593|HGNC:HGNC:952|ENSEMBL:ENSG00000138376|HPRD:03354|Vega:OTTHUMG00000133016 |
基因类型 | 蛋白质编码 |
Map location | 2q35 |
Pascal p-value | 0.26 |
Sherlock p-value | 0.701 |
胎儿β | 1.216 |
主持人 | Myers' cis & trans 元 |
Gene in Data Sources
基因集名称 | Method of gene set | Description | 信息 |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS | |
PMID:cooccur | High-throughput literature-search | PubMed中的系统搜索与SCZ关键字共发生的基因。总共包括3027个基因。 | |
GSMA_IIA | Genome scan meta-analysis (All samples) | PSR:0.00916 | |
gsma_iie | Genome scan meta-analysis (European-ancestry samples) | Psr: 0.01016 | |
Literature | High-throughput literature-search | Co-occurance with Schizophrenia keywords: schizophrenia,schizophrenias | 点击显示详细信息 |
Network | Shortest path distance of core genes in the Human protein-protein interaction network | Contribution to shortest path in PPI network: 0.3518 |
Section I. Genetics and epigenetics annotation
eQTL annotation
SNP ID | 染色体 | 位置 | 主持人 | Gene Entrez ID | pvalue | QVALUE | TSS距离 | EQTL类型 |
---|---|---|---|---|---|---|---|---|
RS9789570 | CHR2 | 215694649 | Bard1 | 580 | 0.01 | 顺式 | ||
rs2166458 | CHR2 | 215716168 | Bard1 | 580 | 0 | 顺式 | ||
RS777307 | CHR2 | 215731208 | Bard1 | 580 | 0.18 | 顺式 | ||
rs7578759 | CHR2 | 215798407 | Bard1 | 580 | 0.17 | 顺式 | ||
RS1409612 | CHR2 | 215800709 | Bard1 | 580 | 0.03 | 顺式 | ||
rs2166458 | CHR2 | 215716168 | Bard1 | 580 | 0.11 | 反式 | ||
rs1007573 | chr12 | 99092620 | Bard1 | 580 | 0.13 | 反式 |
第二节。转录组注释
一般基因表达(GTEX)
![Not available](http://www.tjghsg.com/bioinfo/SZGR/GeneImg/BARD1_DE_GTEx.png)
Gene expression during devlopment (BrainCloud)
Footnote:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
时间变化的基因表达(brainspan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
死神:胎儿(13 - 26 postconception周),ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
所示的栏表示表达分布的较低25%和上层25%。
大脑区域的顶级共表达基因
Top 10 positively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
USP40 | 0.79 | 0.82 |
CAPN2 | 0.74 | 0.70 |
SLC44A2 | 0.74 | 0.70 |
AK3 | 0.72 | 0.69 |
MCCC2 | 0.72 | 0.69 |
CHD1L | 0.72 | 0.72 |
BMP7 | 0.72 | 0.70 |
ALDH7A1 | 0.72 | 0.72 |
CPT2 | 0.71 | 0.72 |
SEPT2 | 0.71 | 0.74 |
Top 10 negatively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
IL32 | -0.40 | -0.37 |
FAM159B | -0.38 | -0.26 |
AF347015.21 | -0.36 | -0.18 |
RP9P | -0.32 | -0.24 |
TTC9B | -0.31 | -0.28 |
CLEC3B | -0.31 | -0.36 |
AL050337.1 | -0.31 | -0.13 |
AC087071.1 | -0.30 | -0.13 |
AL049792.1 | -0.29 | -0.15 |
AC021914.1 | -0.29 | -0.10 |
第三节。基因本体论注释
分子功能 | 去学期 | 证据 | 神经关键字 | PubMed ID |
---|---|---|---|---|
GO:0003723 | RNA结合 | IDA | 12419249 | |
去:0005515 | 蛋白质结合 | IPI | 8944023|10026184|10477523 |15184379|15265711 |15782130 |
|
GO:0004842 | ubiquitin-protein ligase activity | nas | 15905410 | |
GO:0008270 | zinc ion binding | IEA | - | |
去:0019900 | kinase binding | nas | 15782130 | |
GO:0042803 | 蛋白质同构化活性 | IPI | 15265711 | |
GO:0046872 | metal ion binding | IEA | - | |
GO:0046982 | 蛋白质异二聚化活性 | IPI | 15265711 | |
生物过程 | 去学期 | 证据 | 神经关键字 | PubMed ID |
GO:0001894 | tissue homeostasis | TAS | 15782130 | |
GO:0007050 | cell cycle arrest | nas | 15632137 | |
去:0006974 | 对DNA损伤刺激的反应 | nas | 15905410 | |
GO:0043065 | 凋亡的阳性调节 | IMP | 15782130 | |
GO:0016567 | 蛋白质泛素化 | nas | 15905410 | |
GO:0043066 | negative regulation of apoptosis | IMP | 15265711 | |
GO:0042325 | 调节磷酸化 | IMP | 15782130 | |
GO:0031441 | negative regulation of mRNA 3'-end processing | nas | 15905410 | |
GO:0045732 | positive regulation of protein catabolic process | nas | 15905410 | |
GO:0046826 | negative regulation of protein export from nucleus | IDA | 15265711 | |
Cellular component | 去学期 | 证据 | 神经关键字 | PubMed ID |
GO:0000151 | ubiquitin ligase complex | nas | 14976165 | |
去:0005622 | 细胞内 | IEA | - | |
去:0005634 | nucleus | IDA | 15265711 | |
去:0005634 | nucleus | IMP | 15632137 | |
去:0005737 | cytoplasm | IDA | 15265711 | |
GO:0031436 | BRCA1-BARD1 complex | IDA | 15265711 |
Section IV. Protein-protein interaction annotation
互动者 | 别名b | 官方全名b | 实验 | Source | PubMed ID |
---|---|---|---|---|---|
Bard1 | - | BRCA1相关环域1 | 重构的复合物 | Biogrid | 11257228 |
Bcl3 | BCL4 | D19S37 | B细胞CLL/淋巴瘤3 | - | HPRD,BioGRID | 10362352 |
BRCA1 | Brcai |BRCC1 |虹膜|PSCP |RNF53 | breast cancer 1, early onset | Affinity Capture-MS 亲和力捕获 - 韦斯特恩 共晶结构 共定位 共纯化 FRET 重构的复合物 Two-hybrid |
Biogrid | 8944023|9342365 |9738006|9788437 |10026184|10477523 |10635334|11257228 |11278247|11301010 |11498787|11504724 |11526114|11573085 |11773071|11925436 |11927591|12431996 |12438698|12485996 |12700228|12732733 |12887909|12890688 |12951069|14636569 |14638690|14647430 |15159397|15184379 |
BRCA1 | Brcai |BRCC1 |虹膜|PSCP |RNF53 | breast cancer 1, early onset | - | HPRD | 8944023|10026184 |11573085|11773071 |12431996 |
BRCA1 | Brcai |BRCC1 |虹膜|PSCP |RNF53 | breast cancer 1, early onset | - | HPRD | 8944023|10026184 |11773071|12431996 |
BRCA2 | brcc2 |FACD |时尚|Fad1 |Fancb |fancd |FANCD1 | breast cancer 2, early onset | 共纯化 重构的复合物 |
Biogrid | 14636569 |
BRCC3 | BRCC36 |C6.1A |CXORF53 | BRCA1/BRCA2-containing complex, subunit 3 | Affinity Capture-MS 亲和力捕获 - 韦斯特恩 |
Biogrid | 14636569 |
布雷 | BRCC4 |BRCC45 | 大脑和生殖器官表达(TNFRSF1A调节器) | Affinity Capture-MS 亲和力捕获 - 韦斯特恩 |
Biogrid | 14636569 |
CSTF1 | CstF-50 | CstFp50 | cleavage stimulation factor, 3' pre-RNA, subunit 1, 50kDa | - | HPRD,BioGRID | 10477523|11257228 |
CSTF2 | CstF-64 | 切割刺激因子,3'Pre-RNA,亚基2,64KDA | 亲和力捕获 - 韦斯特恩 共纯化 |
Biogrid | 10477523|11257228 |
E2F1 | E2F-1 |RBAP1 |rbbp3 |rbp3 | E2F transcription factor 1 | E2F1与Bard1启动子相互作用。 | 绑定 | 11799067 |
E2F4 | E2F-4 | E2F转录因子4,P107/P130结合 | E2F4与Bard1启动子区域相互作用。 | 绑定 | 11799067 |
ewsr1 | ews | Ewing sarcoma breakpoint region 1 | - | HPRD,BioGRID | 12183411 |
FANCD2 | DKFZP762A223 |FA-D2 |FA4 |FACD |时尚|Fad2 |fancd |FLJ23826 | Fanconi贫血,互补组D2 | 共定位 重构的复合物 |
Biogrid | 12887909 |
H2AFX | H2A.X | H2A/X | H2AX | H2A histone family, member X | 重构的复合物 | Biogrid | 11927591|12485996 |
Hist2H2AB | - | 组蛋白簇2,H2AB | 重构的复合物 | Biogrid | 11927591 |
ING5 | FLJ23842 | p28ING5 | 成长家族抑制剂,成员5 | - | HPRD | 15383276 |
Med17 | CRSP6 | CRSP77 | DRIP80 | FLJ10812 | TRAP80 | mediator complex subunit 17 | 共纯化 | Biogrid | 12154023 |
MSH2 | COCA1 | FCC1 | HNPCC | HNPCC1 | LCFS2 | MUTS同源物2,结肠癌,非型型1型(大肠杆菌) | - | HPRD,BioGRID | 11498787 |
MSH3 | DUP | MGC163306 | MGC163308 | MRP1 | MUTS同源物3(大肠杆菌) | 重构的复合物 | Biogrid | 11498787 |
MSH6 | GTBP | HNPCC5 | HSAP | mutS homolog 6 (E. coli) | 重构的复合物 | Biogrid | 11498787 |
nfkbiA | ikba |Mad-3 |nfkbi | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | Two-hybrid | Biogrid | 10362352 |
NPM1 | B23 | MGC104254 | NPM | nucleophosmin (nucleolar phosphoprotein B23, numatrin) | Affinity Capture-MS 亲和力捕获 - 韦斯特恩 重构的复合物 |
Biogrid | 15184379 |
polr2a | MGC75453 | POLR2 | POLRA | RPB1 | RPBh1 | RPO2 | RPOL2 | RpIILS | hRPB220 | hsRPB1 | polymerase (RNA) II (DNA directed) polypeptide A, 220kDa | - | HPRD | 12154023 |
POU2F1 | OCT1 | OTF1 | POU class 2 homeobox 1 | - | HPRD | 11777930 |
RAD51 | BRCC5 |hrad51 |HSRAD51 |HST16930 |rad51a |reca | RAD51homolog (RecA homolog, E. coli) (S. cerevisiae) | Affinity Capture-MS 亲和力捕获 - 韦斯特恩 |
Biogrid | 14636569 |
RBBP8 | ctip |轮缘 | retinoblastoma binding protein 8 | - | HPRD,BioGRID | 10764811 |
RELA | MGC131774 |NFKB3 |P65 | V-REL网状内皮症病毒性癌基因同源物A(Avian) | 亲和力捕获 - 韦斯特恩 | Biogrid | 12700228 |
tcerg1 | CA150 |MGC133200 |taf2s | 转录伸长调节器1 | - | HPRD | 15383276 |
TP53 | FLJ92943 | LFS1 | TRP53 | p53 | 肿瘤蛋白p53 | Affinity Capture-MS 亲和力捕获 - 韦斯特恩 |
Biogrid | 14636569 |
TP53 | FLJ92943 | LFS1 | TRP53 | p53 | 肿瘤蛋白p53 | TP53 (p53) interacts with BARD1. | 绑定 | 15782130 |
UBA1 | A1S9 |A1S9T |a1st |AMCX1 |GXP1 |MGC4781 |smax2 |Uba1a |ube1 |ube1x | ubiquitin-like modifier activating enzyme 1 | 重构的复合物 | Biogrid | 11278247|11927591 |12431996|12438698 |12485996|12887909 |15184379 |
ube2d1 | E2(17)KB1 | SFT | UBC4/5 | UBCH5 | UBCH5A | ubiquitin-conjugating enzyme E2D 1 (UBC4/5 homolog, yeast) | 重构的复合物 | Biogrid | 11278247|11927591 |12438698|12485996 |12887909|12890688 |14636569|15184379 |
ube2d2 | E2(17)KB2 | PUBC1 | UBC4 | UBC4/5 | UBCH5B | ubiquitin-conjugating enzyme E2D 2 (UBC4/5 homolog, yeast) | 重构的复合物 | Biogrid | 12431996 |
ube2d3 | E2(17)KB3 | MGC43926 | MGC5416 | UBC4/5 | UBCH5C | 泛素结合酶E2d 3(UBC4/5同源物,酵母) | - | HPRD | 12732733 |
UBE2L3 | E2-F1 | L-UBC | UBCH7 | UbcM4 | 泛素结合酶E2L 3 | - | HPRD | 12732733 |
UBE3A | ancr |AS |e6-ap |epve6ap |FLJ26981 |HPVE6A | ubiquitin protein ligase E3A | 重构的复合物 | Biogrid | 12890688 |
xist | DKFZP779P0129 |DXS1089 |DXS399E |NCRNA00001 |SXI1 |XCE |xic |SWD66 | X(非活动) - 特异性转录本(非蛋白质编码) | 共定位 | Biogrid | 12419249 |
XRCC6 | CTC75 | CTCBF | G22P1 | KU70 | ML8 | TLAA | X射线修复补充中国仓鼠细胞中有缺陷的修复6 | BARD1与XRCC6 (Ku70)。 | 绑定 | 15782130 |
ZHX1 | - | zinc fingers and homeoboxes 1 | - | HPRD | 15383276 |
Section V. Pathway annotation
路径名 | 路径大小 | # SZGR 2.0 genes in pathway | 信息 |
---|---|---|---|
PID BARD1 PATHWAY | 29 | 19 | 所有SZGR 2。0genes in this pathway |
西部肾上腺皮质肿瘤标记 | 21 | 13 | 所有SZGR 2。0genes in this pathway |
PYEON HPV POSITIVE TUMORS UP | 98 | 47 | 所有SZGR 2。0genes in this pathway |
CHEMNITZ RESPONSE TO PROSTAGLANDIN E2 UP | 146 | 86 | 所有SZGR 2。0genes in this pathway |
Corre多发性骨髓瘤DN | 62 | 41 | 所有SZGR 2。0genes in this pathway |
vecchi胃癌早期 | 430 | 232 | 所有SZGR 2。0genes in this pathway |
Gargalovic对氧化磷脂绿松石DN的反应 | 53 | 25 | 所有SZGR 2。0genes in this pathway |
莱茵所有糖皮质激素治疗DN | 362 | 238 | 所有SZGR 2。0genes in this pathway |
Senese HDAC3靶向DN | 536 | 332 | 所有SZGR 2。0genes in this pathway |
KINSEY TARGETS OF EWSR1 FLII FUSION UP | 1278 | 748 | 所有SZGR 2。0genes in this pathway |
Kim WT1靶向DN | 459 | 276 | 所有SZGR 2。0genes in this pathway |
HAHTOLA SEZARY SYNDROM UP | 98 | 58 | 所有SZGR 2。0genes in this pathway |
hahtola兄弟姐妹Fungoides皮肤 | 177 | 113 | 所有SZGR 2。0genes in this pathway |
Tang衰老TP53靶向DN | 57 | 33 | 所有SZGR 2。0genes in this pathway |
RIZ ERYTHROID DIFFERENTIATION HBZ | 41 | 27 | 所有SZGR 2。0genes in this pathway |
DACOSTA UV RESPONSE VIA ERCC3 DN | 855 | 609 | 所有SZGR 2。0genes in this pathway |
Dacosta UV响应通过ERCC3公共DN | 483 | 336 | 所有SZGR 2。0genes in this pathway |
KIM MYCN扩增靶向DN | 103 | 59 | 所有SZGR 2。0genes in this pathway |
Pujana乳腺癌点燃int网络 | 101 | 73 | 所有SZGR 2。0genes in this pathway |
PUJANA BRCA1 PCC网络 | 1652 | 1023 | 所有SZGR 2。0genes in this pathway |
Pujana BRCA2 PCC网络 | 423 | 265 | 所有SZGR 2。0genes in this pathway |
PUJANA CHEK2 PCC网络 | 779 | 480 | 所有SZGR 2。0genes in this pathway |
Buytaert光动力疗法应力DN | 637 | 377 | 所有SZGR 2。0genes in this pathway |
狮子转移 | 539 | 324 | 所有SZGR 2。0genes in this pathway |
BENPORATH MYC MAX TARGETS | 775 | 494 | 所有SZGR 2。0genes in this pathway |
Benporath循环基因 | 648 | 385 | 所有SZGR 2。0genes in this pathway |
Mir192和Mir215的Georges目标 | 893 | 528 | 所有SZGR 2。0genes in this pathway |
尼尔森对雄激素DN的反应 | 19 | 14 | 所有SZGR 2。0genes in this pathway |
彭谷氨酰胺剥夺 | 38 | 25 | 所有SZGR 2。0genes in this pathway |
MANALO HYPOXIA DN | 289 | 166 | 所有SZGR 2。0genes in this pathway |
Pomeroy髓母细胞瘤预后DN | 43 | 28 | 所有SZGR 2。0genes in this pathway |
REN BOUND BY E2F | 61 | 40 | 所有SZGR 2。0genes in this pathway |
Sasaki成人T细胞白血病 | 176 | 122 | 所有SZGR 2。0genes in this pathway |
MOREAUX B LYMPHOCYTE MATURATION BY TACI DN | 73 | 45 | 所有SZGR 2。0genes in this pathway |
FERRANDO T ALL WITH MLL ENL FUSION DN | 87 | 57 | 所有SZGR 2。0genes in this pathway |
HADDAD B淋巴细胞祖细胞 | 293 | 193 | 所有SZGR 2。0genes in this pathway |
VERNELL RETINOBLASTOMA PATHWAY UP | 70 | 47 | 所有SZGR 2。0genes in this pathway |
Zhan V2晚分化基因 | 45 | 34 | 所有SZGR 2。0genes in this pathway |
TACI DN的Moreaux多发性骨髓瘤 | 172 | 107 | 所有SZGR 2。0genes in this pathway |
ly老龄过早的DN | 30 | 17 | 所有SZGR 2。0genes in this pathway |
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 2 | 50 | 34 | 所有SZGR 2。0genes in this pathway |
KANG阿霉素耐药性 | 54 | 33 | 所有SZGR 2。0genes in this pathway |
SONG TARGETS OF IE86 CMV PROTEIN | 60 | 42 | 所有SZGR 2。0genes in this pathway |
LY AGING OLD DN | 56 | 35 | 所有SZGR 2。0genes in this pathway |
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 1 | 419 | 273 | 所有SZGR 2。0genes in this pathway |
CREIGHTON ENDOCRINE THERAPY RESISTANCE 1 | 528 | 324 | 所有SZGR 2。0genes in this pathway |
由E2F4绑定的Marson未刺激 | 728 | 415 | 所有SZGR 2。0genes in this pathway |
Sarrio上皮间质转变 | 180 | 114 | 所有SZGR 2。0genes in this pathway |
DE YY1 TARGETS DN | 92 | 64 | 所有SZGR 2。0genes in this pathway |
Dairkee Cancer俯卧反应BPA E2 | 118 | 65 | 所有SZGR 2。0genes in this pathway |
TOYOTA TARGETS OF MIR34B AND MIR34C | 463 | 262 | 所有SZGR 2。0genes in this pathway |
WEST ADRENOCORTICAL TUMOR UP | 294 | 199 | 所有SZGR 2。0genes in this pathway |
对Salirasib dn的Blum响应 | 342 | 220 | 所有SZGR 2。0genes in this pathway |
FRASOR RESPONSE TO SERM OR FULVESTRANT DN | 50 | 29 | 所有SZGR 2。0genes in this pathway |
Ruiz TNC靶向DN | 142 | 79 | 所有SZGR 2。0genes in this pathway |
CHANG CYCLING GENES | 148 | 83 | 所有SZGR 2。0genes in this pathway |
BOYAULT LIVER CANCER SUBCLASS G123 UP | 45 | 21 | 所有SZGR 2。0genes in this pathway |
CHIANG LIVER CANCER SUBCLASS PROLIFERATION UP | 178 | 108 | 所有SZGR 2。0genes in this pathway |
Kobayashi EGFR信令24小时DN | 251 | 151 | 所有SZGR 2。0genes in this pathway |
FOURNIER ACINAR DEVELOPMENT LATE 2 | 277 | 172 | 所有SZGR 2。0genes in this pathway |
PYEON CANCAR CANCAR HEAD和NECK与颈椎 | 193 | 95 | 所有SZGR 2。0genes in this pathway |
Hahtola CTCL皮肤 | 26 | 19 | 所有SZGR 2。0genes in this pathway |
由MYC约束 | 1103 | 714 | 所有SZGR 2。0genes in this pathway |
ZEMBUTSU SENSITIVITY TO VINCRISTINE | 19 | 10 | 所有SZGR 2。0genes in this pathway |
BROWNE HCMV INFECTION 4HR DN | 254 | 158 | 所有SZGR 2。0genes in this pathway |
惠特菲尔德细胞周期G1 S | 147 | 76 | 所有SZGR 2。0genes in this pathway |
Dutertre雌二醇反应24小时 | 324 | 193 | 所有SZGR 2。0genes in this pathway |
JOHNSTONE PARVB TARGETS 3 DN | 918 | 550 | 所有SZGR 2。0genes in this pathway |
RAO BOUND BY SALL4 ISOFORM B | 517 | 302 | 所有SZGR 2。0genes in this pathway |